Pharacokinetics I/II - Patel Flashcards
Vd
Volume of distribution - the “apparent” volume that relates the amount of the drug in the body to the concentration in the blood. The “imaginary container” that is required to account for the total amount of drug in the body. DOES NOT relate to physiological volumes, only conceptual.
Amount of drug in the body/initial drug concentration
=Ab/Co
=F*dose/Co
Units: L or ml
Pharmacokinetics
The study of the disposition of a drug and/or its metabolites in the body based on time. Pharmacokinetics is an attempt to model how the body acts upon a drug in a systematic manner, by utilizing mathematical correlates adapted to the graphical representation of variables such as time and serum or plasma concentration.
Obese patient alterations
T1/2 increases for lipophilic drugs
Vd: increases for lipophilic drugs, decreases for hydrophilic drugs, CL (clearance) is increased in patients with normal renal fxn
Albumin bound medications are unlikely to be altered in obese patients
CO (cardiac output) increases
Normal W patient - 5% CO goes to adipose tissue
Obese patient - 2% CO goes to adipose tissue
Determinants: Protein Binding
Drug properties: pKa, concentration
Protein: Albumin, alpha1-glycoprotein (higher acidic or basic drugs bind more frequently
Protein affinity: Highly protein bound drugs have a lower CL(hepatic), amount of free drug determines clinical effect. Higher protein binding drugs may require more amount to create clinical effect.
Drug interactions: high protein binding, Uremia
Protein Binding
Most bind to blood protein (albumin), bound drugs stay in plasma, free drugs cross capillary wall = tissues, unbound and unionized drugs can cross placenta and BBB
Bioavailability (F)
Fraction of drug absorbed from a given dose.
Does not consider rate of absorption
Ab (amount absorbed) = F * dose
F is usually given as a percent, which needs to be converted to a decimal.
IV administration is always F=1 (direct)
First-Pass Elimination
Consists of the amount of drug transported to the liver after being absorbed by the gut wall, prior to being transported to into circulation
**IV , inhalation, and sublingual administration bypass 1st pass elimination
Concentrates amount of drug at action site
Phase I metabolism
Hydrolyses
Oxidation - CYP450 reactions
Reduction
**Patients with liver disease have trouble metabolizing phase I drugs.
Phase II Metabolism
Methylation Acetylation Glucuronidation Glutathione conjugation Glycine conjugation Sulfation
CYP450 Induction
Certain drugs when administered concomitantly can increase the activity of an CYP450 enzyme
CYP450 Inhibition
Certain drugs when administered concomitantly can decrease the activity of an CYP450 enzyme
Elimination
Metabolism - EX transformation from lipophilic to hydrophilic
Excretion - elimination of the parent drug/metabolite from the body
Clearance - Removal of drug from a given volume in specific time frame (ml/min)
Factors effecting CL
Impaired hepatic/renal fxn Protein binding/ionizing Blood flow to kidney/liver Smoking Concurrent medications (interactions)
Clearance (CL)
Renal CL = 100 ml/min
CON = 5 mg/ml so, 500 mg in 100 ml or in 1 min, 500 mg of drug will be eliminated.
=Vd * Ke
Zero Order Elimination Rate
Amount of drug eliminated at a constant rate
K is constant that relates amount in body/time
Units=mg/hr
A=Ao-(rate of elimination) * t